Hemophilia is among the oldest known genetic bleeding disorders — shaping royal histories, medical breakthroughs, and today’s gene-therapy hope.
2nd Century AD — earliest clues
Jewish texts described boys who bled endlessly after circumcision — families carrying a mysterious bleeding tendency long before science had a name for it.
Middle Ages
Scattered cases across Europe and the Middle East were often blamed on curses or fate. Understanding lagged; suffering did not.
19th Century — the “Royal Disease”
Queen Victoria carried the gene. Through royal marriages, hemophilia reached courts in Spain, Germany, and Russia. Tsarevich Alexei of Russia became the most famous royal patient — his illness intertwined with politics and Rasputin’s rise.
20th Century science
- Hemophilia A — Factor VIII deficiency
- Hemophilia B — Factor IX deficiency (Christmas Disease)
Plasma transfusions and cryoprecipitate offered the first real control over bleeding episodes.
Modern breakthroughs — and hard lessons
Home factor therapy transformed lives. Contaminated blood products in the 1980s caused HIV and hepatitis tragedies — pushing safer screening and recombinant factors. Today: prophylaxis, Emicizumab-era options, and gene therapy clinical progress.
Hemophilia today
No longer just a “royal disease” — a global health challenge. With awareness and organizations like HSA, people with hemophilia can live fuller, braver lives.
History teaches us this: care + awareness can rewrite a family’s future.
